CCP
AMED

Clough Capital Partners’s Amedisys AMED Stock Holding History

Clough Capital Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-275,900
Closed -$4.11M – 199
2014
Q1 		$4.11M Buy
275,900
+3,100
+1% +$47.7K 0.13% 139
2013
Q4 		$3.99M Buy
+272,800
New +$4.39M 0.13% 142

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clough Capital Partners's AMED Position: Q2 2014 in Review

Clough Capital Partners sold out of Amedisys (AMED) in Q2 2014, closing a stake of 275,900 shares — an estimated $4.11M sold.

Clough Capital Partners first reported a position in AMED in Q4 2013 and held it in 2 quarters. The position peaked at $4.11M in Q1 2014. 124 funds tracked by Wall St. Rank hold AMED as of Q2 2014.

  • Clough Capital Partners reported no remaining Amedisys position as of Q2 2014 after selling out during the quarter.
  • Clough Capital Partners sold 275,900 Amedisys shares in Q2 2014, an estimated $4.11M.
  • Clough Capital Partners first reported a position in Amedisys in Q4 2013 and held it in 2 quarters.
  • Clough Capital Partners's Amedisys position peaked at $4.11M in Q1 2014.
  • 124 funds tracked by Wall St. Rank held Amedisys as of Q2 2014.

Based on Clough Capital Partners's 13F filing for Q2 2014, filed 14 Aug 2014.